131 related articles for article (PubMed ID: 32224717)
1. Expression of Programmed Cell Death Proteins in Kaposi Sarcoma and Cutaneous Angiosarcoma.
Gambichler T; Koim S; Wrobel M; Käfferlein HU; Brüning T; Stockfleth E; Becker JC; Lang K
J Immunother; 2020 Jun; 43(5):169-174. PubMed ID: 32224717
[TBL] [Abstract][Full Text] [Related]
2. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
3. PD-1 and PD-L1 expression in Kaposi sarcoma: A comparative study according to the pathological stage and clinical characteristics.
Kim YJ; Jung CJ; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
J Cutan Pathol; 2021 Feb; 48(2):221-228. PubMed ID: 32779238
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of classic and HIV-viremic and aviremic AIDS Kaposi sarcoma.
Séverin D; Bessaoud F; Meftah N; Du Thanh A; Tretarre B; Guillot B; Makinson A
AIDS; 2021 Mar; 35(3):399-405. PubMed ID: 33181532
[TBL] [Abstract][Full Text] [Related]
5. Regulation of programmed cell death ligand 1 expression by atypical protein kinase C lambda/iota in cutaneous angiosarcoma.
Kawamura A; Kawamura T; Riddell M; Hikita T; Yanagi T; Umemura H; Nakayama M
Cancer Sci; 2019 May; 110(5):1780-1789. PubMed ID: 30801864
[TBL] [Abstract][Full Text] [Related]
6. One hundred and five Kaposi sarcoma patients: a clinical study in Xinjiang, Northwest of China.
Wu XJ; Pu XM; Kang XJ; Halifu Y; An CX; Zhang DZ; Yakeya B; Mijit J
J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1545-52. PubMed ID: 25350316
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of the HHV-8 vGCR cellular homolog gene in AIDS-associated and classic Kaposi's sarcoma: potential role of HIV-1 Tat.
Yen-Moore A; Hudnall SD; Rady PL; Wagner RF; Moore TO; Memar O; Hughes TK; Tyring SK
Virology; 2000 Feb; 267(2):247-51. PubMed ID: 10662620
[TBL] [Abstract][Full Text] [Related]
8. Kaposi Sarcoma and Cutaneous Angiosarcoma: Guidelines for Diagnosis and Treatment.
Requena C; Alsina M; Morgado-Carrasco D; Cruz J; Sanmartín O; Serra-Guillén C; Llombart B
Actas Dermosifiliogr (Engl Ed); 2018 Dec; 109(10):878-887. PubMed ID: 30262126
[TBL] [Abstract][Full Text] [Related]
9. Treatment outcomes of patients with classic and AIDS-related Kaposi Sarcoma: a single-center real-world experience.
Valcarcel-Valdivia B; Enriquez-Vera D; Piedra LE; Holguín A; De la Cruz Ku G
Clin Exp Med; 2023 Dec; 23(8):5463-5471. PubMed ID: 37940724
[TBL] [Abstract][Full Text] [Related]
10. Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study.
Mletzko S; Pinato DJ; Robey RC; Dalla Pria A; Benson P; Imami N; Bower M
Oncoimmunology; 2017; 6(8):e1304337. PubMed ID: 28919987
[TBL] [Abstract][Full Text] [Related]
11. CD4+ and CD8+ T-cell skewness in classic Kaposi sarcoma.
Galleu A; Fozza C; Simula MP; Contini S; Virdis P; Corda G; Pardini S; Cottoni F; Pruneddu S; Angeloni A; Ceccarelli S; Longinotti M
Neoplasia; 2012 Jun; 14(6):487-94. PubMed ID: 22787430
[TBL] [Abstract][Full Text] [Related]
12. Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma.
Brown LF; Dezube BJ; Tognazzi K; Dvorak HF; Yancopoulos GD
Am J Pathol; 2000 Jun; 156(6):2179-83. PubMed ID: 10854238
[TBL] [Abstract][Full Text] [Related]
13. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 Expression in Cutaneous Angiosarcomas: A Systematic Review with Meta-Analysis.
Lobrano R; Paliogiannis P; Zinellu A; Palmieri G; Persico I; Mangoni AA; Cossu A
Curr Oncol; 2023 May; 30(5):5135-5144. PubMed ID: 37232846
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment.
D'Angelo SP; Shoushtari AN; Agaram NP; Kuk D; Qin LX; Carvajal RD; Dickson MA; Gounder M; Keohan ML; Schwartz GK; Tap WD
Hum Pathol; 2015 Mar; 46(3):357-65. PubMed ID: 25540867
[TBL] [Abstract][Full Text] [Related]
16. Clinical and prognostic significance of PD-1 and PD-L1 expression in sarcomas.
Paydas S; Bagir EK; Deveci MA; Gonlusen G
Med Oncol; 2016 Aug; 33(8):93. PubMed ID: 27421997
[TBL] [Abstract][Full Text] [Related]
17. The role of immunosuppression and immune-activation in classic Kaposi's sarcoma.
Touloumi G; Hatzakis A; Potouridou I; Milona I; Strarigos J; Katsambas A; Giraldo G; Beth-Giraldo E; Biggar RJ; Mueller N; Trichopoulos D
Int J Cancer; 1999 Sep; 82(6):817-21. PubMed ID: 10446447
[TBL] [Abstract][Full Text] [Related]
18. Infiltration of PD-1-positive cells in combination with tumor site PD-L1 expression is a positive prognostic factor in cutaneous angiosarcoma.
Honda Y; Otsuka A; Ono S; Yamamoto Y; Seidel JA; Morita S; Hirata M; Kataoka TR; Takenouchi T; Fujii K; Kanekura T; Okubo Y; Takahashi K; Yanagi T; Hoshina D; Hata H; Abe R; Fujimura T; Funakoshi T; Yoshino K; Masuzawa M; Amoh Y; Tanaka R; Fujisawa Y; Honda T; Kabashima K
Oncoimmunology; 2017; 6(1):e1253657. PubMed ID: 28197370
[TBL] [Abstract][Full Text] [Related]
19. Classic Kaposi sarcoma. Which KSHV-seropositive individuals are at risk?
Guttman-Yassky E; Dubnov J; Kra-Oz Z; Friedman-Birnbaum R; Silbermann M; Barchana M; Bergman R; Sarid R
Cancer; 2006 Jan; 106(2):413-9. PubMed ID: 16353205
[TBL] [Abstract][Full Text] [Related]
20. Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma.
Brown EE; Whitby D; Vitale F; Marshall V; Mbisa G; Gamache C; Lauria C; Alberg AJ; Serraino D; Cordiali-Fei P; Messina A; Goedert JJ
Cancer; 2006 Nov; 107(9):2282-90. PubMed ID: 16998933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
